From gene to therapy: individually adapted cancer medicine Stefan Fröhling is Managing Director...

We take a deep breath and look back on a year which course no one could have imagined this way. What...

Looking ahead to 2021 is associated with countless uncertainties, especially for the culture and...

From December 9 to 11, the NCT Heidelberg will be hosting a virtual benefit concert "Takte gegen...

“Molecular glue degraders” are a new class of cancer drugs, which “glue” cancer growth-promoting...

Press release of the German Cancer Research Center (DKFZ) with a supplement by the NCT Heidelberg

Women are at higher risk of developing breast cancer if the cancer already occurred in a...

Joint press release from NCT Heidelberg und KiTZ

Due to the current pandemic developments, the UKHD task force has decided that from Monday 19.10.20...

The prestigious European cancer association Cancer Core Europe (CCE) joint forces again with its...